Eikon Therapeutics
EIKN · NASDAQ
$8.18+$0.48 (+6.23%)TodayMarket closed ·
Prev close $7.70
Who owns EIKN
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 55.3% of EIKN’s shares.
- Lux Capital Management, LLC10.5%
- Fidelity Management & Research Company LLC9.1%
- The Column Group LP7.2%
- Foresite Capital Management, LLC6.0%
- Next 6 largest institutions22.5%
- All other shareholders44.7%
| Holder | Shares | % of shares |
|---|---|---|
| Lux Capital Management, LLC | 5.70M | 10.52% |
| Fidelity Management & Research Company LLC | 4.93M | 9.11% |
| The Column Group LP | 3.89M | 7.18% |
| Foresite Capital Management, LLC | 3.26M | 6.03% |
| Abu Dhabi Investment Authority | 2.82M | 5.20% |
| Innovation Endeavors III, L.P. | 2.72M | 5.03% |
| Catalyst4 Inc | 1.72M | 3.18% |
| Merck & Co Inc | 1.67M | 3.08% |
| Mahler International Ltd | 1.66M | 3.07% |
| T. Rowe Price Investment Management, Inc. | 1.60M | 2.95% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| BGF World Healthscience Fund | 1.52M | 2.81% |
| Fidelity Contrafund | 1.27M | 2.35% |
| Fidelity Select Biotechnology Portfolio | 1.15M | 2.13% |
| American Funds SMALLCAP World Fund | 1.14M | 2.11% |
| T. Rowe Price Small Cap Value Fund | 926.05K | 1.71% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $1.03M (1 trade) of EIKN on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Column Group IV GP, LP | Buy | 89.20K | $1.03M |
Short interest
Settled Sep 30, 2026
- Shares short
- 6.29M
- Days to cover
- 8.79
- % of shares outstanding
- 11.63%
- Average daily volume
- 716.05K
- Change since last report
- +15.4%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.